These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16279142)

  • 1. Ethics and evidence in clinical trials.
    Goodman SN
    Clin Trials; 2005; 2(3):195-6. PubMed ID: 16279142
    [No Abstract]   [Full Text] [Related]  

  • 2. Pursuit of truly independent data monitoring committees in research.
    Marston L; McKenzie DR; Freemantle N
    BMJ; 2016 May; 353():i2309. PubMed ID: 27172924
    [No Abstract]   [Full Text] [Related]  

  • 3. What should be done about bias and misconduct in clinical trials?
    Fairman KA; Curtiss FR
    J Manag Care Pharm; 2009 Mar; 15(2):154-60. PubMed ID: 19236130
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood, sweat and tears.
    Magnus D
    Am J Bioeth; 2006; 6(3):1-2. PubMed ID: 16754438
    [No Abstract]   [Full Text] [Related]  

  • 6. Federal drug agency gets flack about human subjects protections in clinical trials.
    Beckman M
    J Natl Cancer Inst; 2008 Jan; 100(2):90-1. PubMed ID: 18182612
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study reflections: another view: Commentary on: "Raising suspicions with the Food and Drug Administration: detecting misconduct".
    Spitzig P
    Sci Eng Ethics; 2010 Dec; 16(4):705-11. PubMed ID: 21052860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 9. Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerations.
    Rockhold FW; Enas GG
    Stat Med; 1993 Mar; 12(5-6):471-9. PubMed ID: 8493425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics and eplerenone.
    Gupta S; Fugh-Berman AJ; Scialli A
    J Med Ethics; 2013 Feb; 39(2):110-4. PubMed ID: 23015747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues during the conduct of clinical trials.
    Silverman H
    Proc Am Thorac Soc; 2007 May; 4(2):180-4; discussion 184. PubMed ID: 17494728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer research and clinical trial in action: an important exercise before you embark on your study.
    Carbone L; Kurtzman SH; Leong SP
    Cancer Treat Res; 2007; 132():291-309. PubMed ID: 17305029
    [No Abstract]   [Full Text] [Related]  

  • 13. Central IRBs: why are some institutions reluctant to sign on?
    McNeil C
    J Natl Cancer Inst; 2005 Jul; 97(13):953-5. PubMed ID: 15998943
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergency research and consent: keeping the exception from undermining the rule.
    Derse AR
    Am J Bioeth; 2006; 6(3):36-7; discussion W49-50. PubMed ID: 16754448
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
    Mann H; Shamoo AE
    Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA strengthens its stance against unethical researchers.
    Palmer R
    Nat Med; 2010 Jul; 16(7):728. PubMed ID: 20613734
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Playing safe and preserving integrity: making the FDA model work.
    Wittes J
    Stat Med; 2004 May; 23(10):1523-5. PubMed ID: 15122731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data monitoring committees for pragmatic clinical trials.
    Ellenberg SS; Culbertson R; Gillen DL; Goodman S; Schrandt S; Zirkle M
    Clin Trials; 2015 Oct; 12(5):530-6. PubMed ID: 26374679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical and scientific implications of the globalization of clinical research.
    Andrews CA
    N Engl J Med; 2009 Jun; 360(26):2793; author reply 2793. PubMed ID: 19557890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.